Thousands of lawsuits have recently been filed by victims of the popular anti-blood clotting drug Xarelto, which can lead to uncontrollable bleeding in users due to its lack of a bleeding antidote. Marketed for its “once a day” dosage, the defective drug also poses risks to consumers when its effects wear off during the day or night, leaving … [Read more...]
Drug Makers Routinely Submit Incomplete Reports of Side Effects to FDA
By Sandra Dalton, Staff Writer When researchers analyzed the serious adverse event reports made to the U.S. Food and Drug Administration (FDA) in 2014, they found that reports filed by drug makers were incomplete more than half of the time, while more than 86% of those filed directly by health professional and consumers were complete. The FDA’s … [Read more...]
Document Claims Drug Makers Deceived a Top Medical Journal
On March 1, 2016, The New York Times put out an article questioning whether or not two major pharmaceutical companies deceived a top medical journal in order to protect their drug. The two companies, Johnson & Johnson and Bayer, are said to have misled editors at The New England Journal of Medicine in regards to their anticlotting drug, … [Read more...]
Xarelto Injury Lawsuits
More than 1,900 Xarelto (rivaroxaban) lawsuits have been filed against Bayer and Johnson & Johnson (J&J), and the number is expected to pass 2,000 soon. A recently published study, funded by Bayer, concluded that Xarelto is safe. Several other studies, not funded by the drug maker, came to far less favorable conclusions. Xarelto can cause … [Read more...]
The Mounting Case against Xarelto from FDA Direct Adverse Drug Reports
In just the last four years, the FDA has raised many separate clarifications with Johnson & Johnson about the blood thinning drug Xarelto. These have included extra black box warnings about the possible contraindications, additional advertising requirements and further possible side effects that were not included on the original FDA approval in … [Read more...]
Recent Comments